Author: prandd

Viravaxx AG and the Medical University of Vienna have launched a project for an integrated platform for immune diagnosis and vaccination for COVID-19

Vienna (Austria), 21 April, 2020. Viravaxx AG, a clinical stage biopharmaceutical company based in Vienna, Austria, announced today that it has launched a project for combating COVID-19 together with the Medical University of Vienna.  In this project an integrated immunodiagnostic and…